|
71
|
276
|
5jt2A |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-bisamide |
|
97
|
307
|
5jgaA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 11c |
|
88
|
306
|
5jgdA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 12 |
|
81
|
306
|
5j7bA |
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, gsk583 complex |
|
90
|
294
|
5k76A |
Irak4 in complex with compound 28 |
|
74
|
288
|
5k0xA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc2541 |
|
75
|
298
|
5jkgA |
The crystal structure of fgfr4 kinase domain in complex with ly2874455 |
|
84
|
305
|
5jfvA |
Crystal structure of trka in complex with pf-05206283 |
|
88
|
323
|
5j9yA |
Egfr-t790m in complex with pyrazolopyrimidine inhibitor 1b |
|
89
|
288
|
5khxA |
Crystal structure of jak1 in complex with pf-4950736 |
|
85
|
295
|
5k7iA |
Irak4 in complex with az3864 |
|
82
|
277
|
5jsmA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-3-vem |
|
86
|
305
|
5jfwA |
Crystal structure of trka in complex with pf-05247452 |
|
87
|
307
|
5jgbA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 10 |
|
77
|
306
|
5j7sA |
Crystal structure of sm1-71 bound to tak1-tab1 |
|
83
|
309
|
5j79A |
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, compound 3 complex |
|
78
|
276
|
5j5sA |
Src kinase in complex with a sulfonamide inhibitor |
|
99
|
312
|
5iuhA |
Crystal structure of the anaplastic lymphoma kinase (alk) in complex with 5d |
|
78
|
271
|
5itaA |
Crystal structure of braf kinase domain bound to az-vem |
|
101
|
312
|
5iugA |
Crystal structure of anaplastic lymphoma kinase (alk) in complex with 5a |
|
84
|
292
|
5imxA |
Anaplastic lymphoma kinase (alk) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-4-amino pyrimidine |
|
82
|
293
|
5i9zA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with danusertib (pha739358) |
|
83
|
291
|
5i9wA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with anp |
|
81
|
284
|
5ia1A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with mln8054 |
|
87
|
292
|
5i9vA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with ags |
|
82
|
286
|
5ia0A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with alisertib (mln8237) |
|
91
|
291
|
5ia2A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with compound 66 |
|
84
|
291
|
5i8aA |
Trka with (6~{r})-3-methylsulfanyl-6-phenyl-1-(1~{h}-pyrazol-3-yl)-6,7-dihydro-5~{h}-thieno[3,4-c]pyridin-4-one |
|
80
|
295
|
5ia3A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with pd173955 |
|
83
|
273
|
5ia4A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with foretinib (xl880) |
|
91
|
293
|
5i9xA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with bosutinib (ski-606) |
|
90
|
297
|
5i9yA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with dasatinib |
|
128
|
447
|
5h0gA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (s)-2-(((1r,4s)-4-(4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-n,4-dimethylpentanamide |
|
87
|
284
|
5i4nA |
Crystal structure of the e596a v617f mutant jak2 pseudokinase domain bound to mg-atp |
|
93
|
304
|
5hznA |
Structure of nvp-aew541 in complex with igf-1r kinase |
|
72
|
311
|
5hvkA |
Crystal structure of limk1 mutant d460n in complex with full-length cofilin-1 |
|
89
|
300
|
5hx8A |
Jak1 complex with 4-[(4-aminocyclohexyl)amino]-3-(1h-benzimidazol-2-yl)-1h-pyridin-2-one |
|
75
|
285
|
5hx6A |
Crystal structure of rip1 kinase with a benzo[b][1,4]oxazepin-4-one |
|
69
|
294
|
5hniX |
Crystal structure of cmet wt with compound 3 |
|
91
|
295
|
5htiA |
Crystal structure of c-met kinase domain in complex with lxm108 |
|
86
|
275
|
5hu9A |
Crystal structure of abl1 in complex with chmfl-074 |
|
80
|
293
|
5horA |
Crystal structure of c-met-m1250t in complex with sar125844. |
|
75
|
269
|
5hieA |
Braf kinase domain b3ac loop deletion mutant in complex with dabrafenib |
|
87
|
299
|
5hlwA |
Crystal structure of c-met mutant y1230h in complex with compound 14 |
|
125
|
447
|
5h0eA |
Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (s)-2-(((1r,4s)-4-(4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanamide |
|
94
|
303
|
5grnA |
Crystal structure of pdgfra in complex with wq-c-159 |
|
81
|
290
|
5gzaA |
Protein o-mannose kinase |
|
78
|
284
|
5gz8A |
Crystal structure of catalytic domain of protein o-mannosyl kinase in ligand-free form |
|
96
|
305
|
5fxrA |
Igfr-1r complex with a pyrimidine inhibitor. |
|
101
|
314
|
4ckjA |
Crystal structure of ret tyrosine kinase domain bound to adenosine |
